Introduction
A novel coronavirus has spread through China, originating from the city of Wuhan and has caused many deaths so far. It is a highly contagious virus that has spread rapidly and efficiently. Coronavirus disease 2019 (COVID-19) is caused by a virus (SARS-CoV-2) from the same family as the lethal coronaviruses that caused severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV). COVID-19 is a relatively large virus (120 nm) and is enveloped, containing a positive-sense single-stranded RNA [1] . The virus is transmitted through direct contact with the infected person's respiratory droplets (coughing and sneezing), as well as contact with infected surfaces. COVID-19 virus can survive for days on surfaces, but a simple disinfectant can eliminate this [2] . COVID-19 signs and symptoms include fever, cough, and shortness of breath. In more severe cases, infection can lead to pneumonia, serious respiratory problems and ultimately, fatalities. Thousands of people have been reported to have been infected with the virus so far [3] . Apart from China, other cases of the disease, also known as COVID-2, have been reported in several countries, including Thailand, South COVID-19 can be diagnosed with diagnostic test kits [9] and imaging techniques such as chest X-ray and pulmonary CT scans that facilitate early diagnosis of pneumonia in patients with COVID-19 [10] [11] [12] .
The case fatality rate (CFR), is a measure of the ability of a pathogen or virus to infect or damage a host in infectious disease and is described as the proportion of deaths within a defined population of interest, i.e. the percentage of cases that result in death [13] . CFRs confers the extent of disease severity and CFR is necessary for setting priorities for public health in targeted interventions to reduce the severity of risk [14] . Initial studies reported an estimation of 3% for the global CFR of COVID-19 [15] . Estimating CFR from country-level data requires assessment of information about the delay between the report of the country-specific cases and death from COVID-19, as well as underestimating and under-reporting of death-related cases, which may not be known. Given the importance of CFR and recovery rate (RR), in this current study the CFR and RR of different countries during a COVID-19 ongoing pandemic was observed using up-to-date countrylevel data.
Materials and Methods

Source of data and procedure
The data were retrieved from accurate databases including Worldometer 2, WHO 3, the Center of Disease Control and Prevention [16] , and the Morbidity and Mortality Weekly
Report series (provided from Center of Disease Control and Prevention), according to the user's guide of data sources for patient registries [17] . Due to the rapid increase in data, the analysis in this study was performed on the 12 th and 23 rd of
March 2020.
Raw data was mapped according to countries and CFR and RR were compared for countries with ≥ 1,000 cases. All countries with < 1,000 cases are presented in supplementary Table 1 . A comparison of CFR with different known viral diseases was performed.
Measuring the CFR and RR
The formulas below were used to measure CFR and RR.
CFR (%) = (Number of deaths due to COVID-19/ Number of closed cases of COVID-19) ×100 RR (%) = (Number of cases recovered from COVID-19/ Number of closed cases of COVID-19) ×100
Results
The total number of confirmed cases of COVID-19 was highest Only countries with total cases over 1,000 are depicted (population in million and GDP in trillion US dollars). GDP = gross domestic product; ICU = intensive care unit. Since the number of cases in the world is increasing in a heterogeneous form, to obtain a better picture for crosscountry compression of medical care performance, we require a limiting denominator of CFR and RR to be applied to cases under official medical care with final disease outcome (death/ recovered or discharged).
Conclusion
Death and severity of COVID-19 are associated with age and comorbidities across the world. Especially in countries with the highest outbreaks, such as China, Italy, and Iran, strategies must be employed to ensure that high-risk groups, such as old people and those with other underlying diseases such as diabetes and cancer, received adequate protection from COVID-19. Therefore, early access to medical care when infected is vital for improving chances of survival.
Improving medical supplies to countries such as Iran, which is significantly influenced by US punitive policies, can reduce the deterioration of this politically sensitive situation [20] . 
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